Literature DB >> 31556210

Abundance of Probiotics and Butyrate-Production Microbiome Manages Constipation via Short-Chain Fatty Acids Production and Hormones Secretion.

Min Zhuang1, Wenting Shang1, Qiuchen Ma1, Padraig Strappe2, Zhongkai Zhou1,3.   

Abstract

SCOPE: The characteristics of gut microbiota and host metabolism are hypothesized to be associated with constipation status, but the regulation mechanism is not fully understood. Thus, the current study investigates the effect of constipation symptoms on gut functionality following the modulation of gut microbiota and metabolites via dietary fiber intervention. METHODS AND
RESULTS: Constipation causes a significantly reduced short-chain fatty acids (SCFAs) production and a higher level of iso-butyrate. The feces of constipated people are characterized with inhibited Faecalibacterium, Ruminococcaceae and Roseburia abundance. Desulfovibrionaceae is identified to be an important endotoxin producer in constipated patients, and a butyrate-enriched SCFAs profile achieved by dietary fiber supplement accelerates gastrointestinal transit and increases the thickness of the mucosal layer, possibly through triggering the secretion of colonic hormones and enhancing the expression of tight junction proteins for maintaining intestinal barrier integrity. More importantly, an interacting regulatory mechanism among SCFAs, in particular butyrate and propionate, may be involved in signaling between the microbiome and host cells in the colon.
CONCLUSION: Gut microbiota, characterized with enriched butyrate-producing and depressed Desulfovibrionaceae bacteria, attenuates constipation symptoms through promoting intestinal hormones secretion and maintaining gut barrier integrity.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  butyrate; constipation; diversity; gut microbiota; metabolites

Year:  2019        PMID: 31556210     DOI: 10.1002/mnfr.201801187

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  17 in total

Review 1.  Gut microbiota: a new avenue to reveal pathological mechanisms of constipation.

Authors:  Lei Yang; Yu Wang; Yun Zhang; Wenwen Li; Shu Jiang; Dawei Qian; Jinao Duan
Journal:  Appl Microbiol Biotechnol       Date:  2022-10-03       Impact factor: 5.560

2.  Photoperiod modulates the gut microbiome and aggressive behavior in Siberian hamsters.

Authors:  Clarissa C Ren; Kristyn E Sylvia; Kathleen M Munley; Jessica E Deyoe; Sarah G Henderson; Michael P Vu; Gregory E Demas
Journal:  J Exp Biol       Date:  2020-01-31       Impact factor: 3.312

3.  27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction.

Authors:  Ying Wang; Yu An; Weiwei Ma; Huiyan Yu; Yanhui Lu; Xiaona Zhang; Yushan Wang; Wen Liu; Tao Wang; Rong Xiao
Journal:  J Neuroinflammation       Date:  2020-06-27       Impact factor: 8.322

4.  Gut Microbiota Composition Changes in Constipated Women of Reproductive Age.

Authors:  Hongxia Li; Jianwei Chen; Xiaojing Ren; Chuanli Yang; Shuai Liu; Xinshu Bai; Shuhua Shan; Xiushan Dong
Journal:  Front Cell Infect Microbiol       Date:  2021-01-21       Impact factor: 5.293

Review 5.  The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS).

Authors:  Sarah L Boddy; Ilaria Giovannelli; Matilde Sassani; Johnathan Cooper-Knock; Michael P Snyder; Eran Segal; Eran Elinav; Lynne A Barker; Pamela J Shaw; Christopher J McDermott
Journal:  BMC Med       Date:  2021-01-20       Impact factor: 8.775

6.  Rhubarb Enema Increasing Short-Chain Fatty Acids that Improves the Intestinal Barrier Disruption in CKD May Be Related to the Regulation of Gut Dysbiosis.

Authors:  Chunlan Ji; Fuhua Lu; Yuchi Wu; Zhaoyu Lu; Yenan Mo; Lijuan Han; Qizhan Lin; Xusheng Liu; Chuan Zou
Journal:  Biomed Res Int       Date:  2022-01-20       Impact factor: 3.411

7.  Effect of fecal microbiota transplantation in patients with slow transit constipation and the relative mechanisms based on the protein digestion and absorption pathway.

Authors:  Lulu Xie; Chen Xu; Yadong Fan; Yuwei Li; Ying Wang; Xiaoyu Zhang; Shuang Yu; Jida Wang; Rundong Chai; Zeyu Zhao; Yutong Jin; Zhe Xu; Shuwu Zhao; Yuhong Bian
Journal:  J Transl Med       Date:  2021-12-01       Impact factor: 5.531

8.  Integrated Analysis of the Cecal Microbiome and Plasma Metabolomics to Explore NaoMaiTong and Its Potential Role in Changing the Intestinal Flora and Their Metabolites in Ischemic Stroke.

Authors:  Huiting Lin; Shaoru Chen; Lin Shen; Tao Hu; Jiale Cai; Sikai Zhan; Jiayin Liang; Mingmin Huang; Minghua Xian; Shumei Wang
Journal:  Front Pharmacol       Date:  2022-01-20       Impact factor: 5.810

9.  Habitual Dietary Fiber Intake, Fecal Microbiota, and Hemoglobin A1c Level in Chinese Patients with Type 2 Diabetes.

Authors:  Jiongxing Fu; Kelin Xu; Xumin Ni; Xiaoqiang Li; Xiaofeng Zhu; Wanghong Xu
Journal:  Nutrients       Date:  2022-02-27       Impact factor: 5.717

10.  Myelin as a regulator of development of the microbiota-gut-brain axis.

Authors:  Ciara E Keogh; Danielle H J Kim; Matteo M Pusceddu; Trina A Knotts; Gonzalo Rabasa; Jessica A Sladek; Michael T Hsieh; Mackenzie Honeycutt; Ingrid Brust-Mascher; Mariana Barboza; Mélanie G Gareau
Journal:  Brain Behav Immun       Date:  2020-11-04       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.